32C-14075-94528
2 vaccinations
5 coded responses
19 check-ins
5 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 234 / VA
- Registered
- 2021-01-29
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-27
Dose 1 — Pfizer-BioNTech
-
2021-01-29
Registered in v-safe
- 2021-01-29
- 2021-01-30
-
2021-01-31
Survey response — days 1–6 daily, dose 1MedDRA: Pregnancy — Feeling: Fair · Fatigue or tiredness, NauseaFree text: PregnancyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-01
Survey response — days 1–6 daily, dose 1MedDRA: Pregnancy — Feeling: Good · Joint pains, Nausea, VomitingFree text: PregnancyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-02
Survey response — days 1–6 daily, dose 1MedDRA: Pregnancy — Feeling: Poor · Muscle or body aches, Fatigue or tiredness, Diarrhea, Abdominal pain · Be unable to do your normal daily activitiesFree text: Currently pregnant with mild spottingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-02
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
-
2021-02-03
Survey response — day 7, dose 1MedDRA: Pregnancy, Subchorionic haematoma — Feeling: Fair · Muscle or body aches, Vomiting · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visitFree text: Pregnancy, spotting due to a subchorionic hematomaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-03
Report sent to call center — day 7, dose 1Get care from a doctor or other healthcare professional1 call case(s)
- 2021-02-10
-
2021-02-16
Dose 2 — Pfizer-BioNTech
-
2021-02-17
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Nausea, Vomiting · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-02-18
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-02-19
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, NauseaAdult check-in
-
2021-02-21
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-02-22
-
2021-02-25
Survey response — day 7, dose 2MedDRA: Rhinitis — Feeling: FairFree text: RhinitisMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-26
- 2021-03-02
- 2021-03-09
- 2021-03-16
- 2021-03-30
- 2021-05-20
- 2021-08-17
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-27 | Pfizer-BioNTech | |
| 2 | 2021-02-16 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-02-02 | Unsuccessful | |
| 2021-02-03 | Unsuccessful |
Free text
Release 3 — days 1–6 daily, dose 1
Systemic reaction (other): Pregnancy
Systemic reaction (other): Pregnancy
Systemic reaction (other): Currently pregnant with mild spotting
Release 3 — day 7, dose 1
Systemic reaction (other): Pregnancy, spotting due to a subchorionic hematoma
Release 4 — day 7, dose 2
Systemic reaction (other): Rhinitis
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Pregnancy | ✓ | ✓ | ✓ |
| SRO | Rhinitis | ✓ | ✓ | ✓ |
| SRO | Subchorionic haematoma | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release